The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Complementary and Incremental Mortality Risk Prediction by Cortisol and Aldosterone in Chronic Heart Failure
Open accessAbstract
Background— In patients with systolic heart failure, high levels of circulating aldosterone are associated with an adverse prognosis, and mineralocorticoid receptor blockade improves survival. The prognostic significance of cortisol that may also bind and activate the mineralocorticoid receptor in chronic heart failure is unknown. Methods and Results— Serum levels of cortisol and aldosterone were quantified in a prospective cohort study of 294 consecutive patients with chronic heart failure [48% were in New York Heart Association functional class III or IV; 58% had systolic heart failure]. During a median follow-up of 803 days (interquartile range, 314 to 1098), 79 patients died (27.3% mortality rate). Cortisol and aldosterone were independent predictors of increased mortality risk in Cox regression analyses adjusted for age, sex, New York Heart Association functional class, C-reactive protein, N-terminal pro-brain natriuretic peptide, sodium, and hypercholesterolemia. The hazard ratio for highest versus lowest tertile of cortisol was 2.72 [95% confidence interval [CI], 1.38 to 5.36; P =0.004], and the hazard ratio for aldosterone was 2.19 (95% CI, 1.23 to 3.93; P =0.008). Patients with both cortisol and aldosterone levels above the respective medians had a 3.4-fold higher mortality risk compared with subjects with both corticosteroids below the median (95% CI, 1.54 to 7.46; P =0.0001). Addition of cortisol and aldosterone levels to the fully adjusted model significantly improved the discriminatory power [increase in Harrell’s C -statistic from 0.80 (95% CI, 0.70 to 0.90) to 0.86 (95% CI, 0.79 to 0.94; P <0.001 for change]. Conclusions— In patients with chronic heart failure, higher serum levels of both cortisol and aldosterone were independent predictors of increased mortality risk that conferred complementary and incremental prognostic value.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
Swedberg, K., Cleland, J., Dargie, H., Drexler, H., Follath, F., Komajda, M., Tavazzi, L., Smiseth, O. A., Gavazzi, A., Haverich, A., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi204 · Cited by 2,260
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
Swedberg, K., Eneroth, P., Kjekshus, J., & Wilhelmsen, L. (1990) · Circulation · doi:10.1161/01.cir.82.5.1730 · Cited by 1,153
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Packer, M. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90167-l · Cited by 1,056
Predictors of mortality and morbidity in patients with chronic heart failure
Pocock, S. J., Wang, D., Pfeffer, M. A., Yusuf, S., McMurray, J. J. V., Swedberg, K. B., Östergren, J., Michelson, E. L., Pieper, K. S., & Granger, C. B. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi555 · Cited by 973
Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol
Van Cauter, E. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.7.2468 · Cited by 951
Heart failure with preserved left ventricular systolic function
Hogg, K., Swedberg, K., & McMurray, J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.046 · Cited by 932
Anker, S. D., Chua, T. P., Ponikowski, P., Harrington, D., Swan, J. W., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · Circulation · doi:10.1161/01.cir.96.2.526 · Cited by 800
Aldosterone in Congestive Heart Failure
Weber, K. T. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000050 · Cited by 770
Glucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731
Pitt, B., Reichek, N., Willenbrock, R., Zannad, F., Phillips, R. A., Roniker, B., Kleiman, J., Krause, S., Burns, D., & Williams, G. H. (2003) · Circulation · doi:10.1161/01.cir.0000091405.00772.6e · Cited by 623
(1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00465-1 · Cited by 494
The relationship between cholesterol and survival in patients with chronic heart failure
Rauchhaus, M., Clark, A. L., Doehner, W., Davos, C., Bolger, A., Sharma, R., Coats, A. J. S., & Anker, S. D. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.016 · Cited by 444
Gender, age, and heart failure with preserved left ventricular systolic function
Masoudi, F. A., Havranek, E. P., Smith, G., Fish, R. H., Steiner, J. F., Ordin, D. L., & Krumholz, H. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02696-7 · Cited by 426
Maeda, K., Tsutamoto, T., Wada, A., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00912-8 · Cited by 418
Predictors of total mortality and sudden death in mild to moderate heart failure
Gradman, A., Deedwania, P., Cody, R., Massie, B., Packer, M., Pitt, B., & Goldstein, S. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90093-4 · Cited by 394
Cortisol Effects on Body Mass, Blood Pressure, and Cholesterol in the General Population
Fraser, R., Ingram, M. C., Anderson, N. H., Morrison, C., Davies, E., & Connell, J. M. C. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1364 · Cited by 370
Pitt, B., Williams, G., Remme, W., Martinez, F., Lopez-Sendon, J., Zannad, F., Neaton, J., Roniker, B., Hurley, S., Burns, D., et al. (2001) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1011119003788 · Cited by 364
Nagata, K., Obata, K., Xu, J., Ichihara, S., Noda, A., Kimata, H., Kato, T., Izawa, H., Murohara, T., & Yokota, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000203772.78696.67 · Cited by 223
Pitt, B. (1995) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877755 · Cited by 205
Beygui, F., Collet, J.-P., Benoliel, J.-J., Vignolles, N., Dumaine, R., Barthélémy, O., & Montalescot, G. (2006) · Circulation · doi:10.1161/circulationaha.106.634626 · Cited by 190
Mode of death in heart failure: findings from the ATLAS trial
Poole-Wilson, P. A., Uretsky, B. F., Thygesen, K., Cleland, J. G. F., Massie, B. M., & Rydén, L. (2002) · Heart · doi:10.1136/heart.89.1.42 · Cited by 145
Ukkola, O., Gagnon, J., Rankinen, T., Thompson, P., Hong, Y., Leon, A., Rao, D., Skinner, J., Wilmore, J., & Bouchard, C. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450001 · Cited by 138
Funder, J. W. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.010 · Cited by 137
The Clinical Implications of Aldosterone Escape in Congestive Heart Failure
Struthers, A. D. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.04.013 · Cited by 128
Young, M. J., Moussa, L., Dilley, R., & Funder, J. W. (2003) · Endocrinology · doi:10.1210/en.2002-220926 · Cited by 121
Straub, R. H., Vogl, D., Gross, V., Lang, B., Schölmerich, J., & Andus, T. (1998) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00535.x · Cited by 114
Vantrimpont, P. J. M. J. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1093 · Cited by 112
Is aldosterone bad for the heart?
Funder, J. W. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.03.006 · Cited by 106
Pitt, B., Stier, C. T., & Rajagopalan, S. (2003) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2003.025 · Cited by 58
Kidney and Adrenocortical Hormones
Kleeman, C. R., Levi, J., & Better, O. S. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180516 · Cited by 43
Prognostic factors in heart failure: Poverty amidst a wealth of variables
Cohn, J. N. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90094-6 · Cited by 29
Jorde, U. P. (2006) · Cardiology in Review · doi:10.1097/01.crd.0000201550.94389.50 · Cited by 19
Bauersachs, J. K. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01400.x · Cited by 12
Self-citationPlasma `cortisol' levels in right and left ventricular failure
Connolly, C. K., & WILLS, M. R. (1969) · Journal of Clinical Pathology · doi:10.1136/jcp.22.5.598 · Cited by 10
Angiotensin II Receptor Antagonists in Chronic Heart Failure
Houghton, A. R. (2002) · Drugs · doi:10.2165/00003495-200262100-00001 · Cited by 5
Harrell, F., Jr. (1996) · doi:10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4
Cited by
Sgk1-Dependent Stimulation of Cardiac Na+/H+Exchanger Nhe1 by Dexamethasone
Voelkl, J., Pasham, V., Ahmed, M. S. E., Walker, B., Szteyn, K., Kuhl, D., Metzler, B., Alesutan, I., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350120 · Cited by 857
Glucocorticoids and cardiovascular disease
Walker, B. R. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0455 · Cited by 529
Biomarkers for the diagnosis and management of heart failure
Castiglione, V., Aimo, A., Vergaro, G., Saccaro, L., Passino, C., & Emdin, M. (2022) · Heart Failure Reviews · doi:10.1007/s10741-021-10105-w · Cited by 512
Diastolic and Systolic Heart Failure Are Distinct Phenotypes Within the Heart Failure Spectrum
Borlaug, B. A., & Redfield, M. M. (2011) · Circulation · doi:10.1161/circulationaha.110.954388 · Cited by 456
Understanding how we age: insights into inflammaging
Baylis, D., Bartlett, D. B., Patel, H. P., & Roberts, H. C. (2013) · Longevity & Healthspan · doi:10.1186/2046-2395-2-8 · Cited by 411
Metadata
- Authors
- Güder, G., Bauersachs, J., Frantz, S., Weismann, D., Allolio, B., Ertl, G., Angermann, C. E., & Störk, S.
- Venue
- Circulation
- Published
- 2007-04-03
- Volume
- 115
- Issue
- 13
- Pages
- 1754-1761
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2008704689
- Cited by
- 292
- References
- 42
- FWCI
- 13.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.